Inspection Record

TJP Labs Inc. — Health Canada Inspection Findings

Health CanadaInspected 2022-11-02 3 findingsLabeling and packagingStability and storageMaterial and supplier control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Labeling and packaging

The importer did not ensure that the foreign sites use to fabricate, package/label, or test drug products met the requirements described in Guidance on Evidence to Demonstrate Drug GMP Compliance of Foreign Sites (GUI-0080).

2Stability and storage

The ongoing stability program for a drug was inadequate.

3Material and supplier control

The availability and/or the content of the written agreement between the raw material vendor and the drug fabricator was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-11-02. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

2025-12-16 · Health Canada · 3 findings2025-01-13 · Health Canada · 13 findings2023-10-18 · Health Canada · 8 findings2023-05-02 · Health Canada · 13 findings2022-04-27 · Health Canada · 6 findings
TJP Labs Inc. findings history — including this company's other documents Health Canada documents, 2022 Go to Findings search